e-learning
resources
Munich 2006
Tuesday 05.09.2006
Hypoxic and inflammatory insults to the pulmonary circulation.
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognoctic value of platelet factor-4 and thrombin-antithrombin complex for pulmonary hypertension among patients with idiopathic interstitial pneumonias
E. N. Popova, E. A. Kogan, A. B. Ponomarev, I. A. Popova, V. I. Osipenko (Moscow, Russian Federation)
Source:
Annual Congress 2006 - Hypoxic and inflammatory insults to the pulmonary circulation.
Session:
Hypoxic and inflammatory insults to the pulmonary circulation.
Session type:
Thematic Poster Session
Number:
3826
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. N. Popova, E. A. Kogan, A. B. Ponomarev, I. A. Popova, V. I. Osipenko (Moscow, Russian Federation). Prognoctic value of platelet factor-4 and thrombin-antithrombin complex for pulmonary hypertension among patients with idiopathic interstitial pneumonias. Eur Respir J 2006; 28: Suppl. 50, 3826
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Angiogenesis and coagulation in the development of pulmonary hypertension in idiopathic interstitial pneumonias (IIP)
Source: Eur Respir J 2005; 26: Suppl. 49, 540s
Year: 2005
Coagulation and anticoagulation in idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2015; 24: 392-399
Year: 2015
Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007
RISE-IIP: Riociguat for the treatment of pulmonary hypertension associated with idiopathic interstitial pneumonia
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017
Platelet function in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion.
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 586s
Year: 2005
Circulating angiopoietins in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Platelet aggregability at night in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 98s
Year: 2002
Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001
Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
D-dimers in patients with chronic obstructive pulmonary disease with or without secondary secondary erythrocytosis
Source: Eur Respir J 2004; 24: Suppl. 48, 14s
Year: 2004
Platelet activity in patients with COPD and concomitant arterial hypertension
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017
Year: 2018
The relationships between PAC-1, CD62P and pulmonary hypertension in chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Chronic thromboembolic pulmonary hypertension (CTEPH) and coagulation defects: Before and after treatment
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept